Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
scientific article published on 4 December 2017
Author/s
author: Trevor A Crowell, Rafael A Larocca, Peter Abbink, Dan H. Barouch, Kayvon Modjarrad, Richard G Jarman, Stephen J Thomas, Michael Boyd, Merlin L Robb, Nelson Michael, Rafael A De La Barrera, Kenneth H Eckels, Michael S Seaman, Christine A Bricault, Kathryn E Stephenson
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.